Inventor
Thangavel Soodamani
IN13 patents
Patents
13 patentsUS9790169B2Oct 17, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO19 citations91
US10959986B2Mar 30, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO3 citations72
US10399932B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019
IDO inhibitors
BRISTOL MYERS SQUIBB CO1 citations71
US11713312B2Aug 1, 2023
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO2 citations70
US11254663B2Feb 22, 2022
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO2 citations70
US10544120B2Jan 28, 2020
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US10246469B2Apr 2, 2019
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US11253525B2Feb 22, 2022
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO1 citations61
US12059420B2Aug 13, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO0 citations51
US12319676B2Jun 3, 2025
Substituted amide compounds useful as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations48
US12030835B2Jul 9, 2024
Substituted amide compounds useful as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations47
US10174044B2Jan 8, 2019
Fused pyridines as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations37